Tenax Therapeutics: 'Hold' TNX-103 Data August 2026 - But With Caution Ahead

Tenax Therapeutics, Inc. downgraded to Hold ahead of Aug 2026 phase 3 TNX-103 data in PH-HFpEF; weigh 6MWD odds, downside, ...
The Manila Times

Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential

Seer is Delivering Clear Progress Against its Strategic Plan and Maintaining Focus on Cost Discipline, Governance Rigor and Product Innovation ...

Moderna stock jumps as pipeline progress and flu shot data lift sentiment

The FDA advisory panel unanimously supported mRNA-1010/mFLUSIVA for adults 50–64 and 65+, and the stock is already reacting ...
Hub

The MVPs of data analytics

The Sports Analytics Research Group employs quantitative analysis to give teams the hard numbers they need to perform better ...

Beyond 3-D: Data scientists introduce novel AI tool to interpret complex biological data

As humans, our eyes take in two-dimensional images that our brains convert to three-dimensional experiences. This ability enables us to be aware of our position in space, judge distances, possess ...

5 takeaways from Anthropic’s big science event

The company rolled out a biology-centric version of Claude and hosted surprisingly forthright conversations about AI and ...

Gemini comes to Google Slides to generate fully native and editable presentations

Building a clean, professional presentation deck from scratch is one of the most reliable ways to eat up an afternoon. Even ...

Anthropic’s Claude Science bets on workflow, not a new model, to win over scientists

Anthropic's Claude Science is a workbench that gives scientists one environment to do computational research, saving them ...
Tech Xplore

Machine-readable dataset speeds environmental review drafting tasks

An innovative partnership has yielded powerful new tools to help federal agencies rapidly synthesize complex data, historical ...

Giving Data Center Builders A Real-Time Picture Of What’s Actually Built

The teams that get full value from reality capture treat human change as the real implementation. They build the new workflow ...

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced ...

Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen

Diranersen presentation will feature Phase 2 CELIA data in early Alzheimer’s disease, including clinical, biomarker and safety results for Biogen’s investigational tau-targeting ASO, following topline ...